Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Viscous Budesonide Suspension (MB-7) in Subjects With Eosinophilic Esophagitis: A Randomized, Placebo-Controlled, Dose-Ranging Study in Children and Adolescents

NCT00762073 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00762073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00762073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Viscous Budesonide Suspension (MB-7) in Subjects With Eosinophilic Esophagitis: A Randomized, Placebo-Controlled, Dose-Ranging Study in Children and Adolescents
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
January 8, 2009
Completion date
April 2, 2010
Enrollment
82 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)